The Anti-Red Tape Authority (ARTA) welcomes the move of the Food and Drug Administration (FDA) for granting the application of a hospital for a Compassionate Special Permit to use Ivermectin on humans with COVID-19.

With this, ARTA urges FDA to continue processing applications from other medical institutions seeking the same permit expeditiously while key agencies conduct further studies on the potential efficacy of the Ivermectin, which is initially known as an anti-parasitic drug, against COVID-19.

For our part, rest assured that ARTA will keep monitoring all pending applications with FDA specially those relating to drugs and devices that are essential during this pandemic.

Again, we reiterate our message to government agencies that inaction during a pandemic can cost the lives of the people.

Kaya po ang inyong ARTA ay patuloy na magmamatyag dahil, sa panahon ng pandemya, ang red tape ay nakamamatay.